Cargando…
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
Neuroendocrine neoplasms (NENs) are mutationally quiet (low number of mutations/Mb), and epigenetic mechanisms drive their development and progression. We aimed at comprehensively characterising the microRNA (miRNA) profile of NENs, and exploring downstream targets and their epigenetic modulation. I...
Autores principales: | Soldevilla, Beatriz, Lens‐Pardo, Alberto, Espinosa‐Olarte, Paula, Carretero‐Puche, Carlos, Molina‐Pinelo, Sonia, Robles, Carlos, Benavent, Marta, Gomez‐Izquierdo, Lourdes, Fierro‐Fernández, Marta, Morales‐Burgo, Patricia, Jimenez‐Fonseca, Paula, Anton‐Pascual, Beatriz, Rodriguez‐Gil, Yolanda, Teijo‐Quintans, Ana, La Salvia, Anna, Rubio‐Cuesta, Beatriz, Riesco‐Martínez, Maria C., Garcia‐Carbonero, Rocio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061291/ https://www.ncbi.nlm.nih.gov/pubmed/36795001 http://dx.doi.org/10.1002/1878-0261.13393 |
Ejemplares similares
-
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2023) -
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance
por: Soldevilla, Beatriz, et al.
Publicado: (2021) -
Chemotherapy in NEN: still has a role?
por: Espinosa-Olarte, Paula, et al.
Publicado: (2021) -
Correction to: Chemotherapy in NEN: still has a role?
por: Espinosa-Olarte, Paula, et al.
Publicado: (2022) -
Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?
por: La Salvia, Anna, et al.
Publicado: (2021)